versiti
Dec 12, 2025, 06:35
Genotyping More Than 300,000 Blood Donors by Versiti
Versiti Blood Research Institute shared a post on LinkedIn:
“Incredible work by our colleagues across Versiti! This case is a powerful example of how decades of scientific investment (in this case, genotyping more than 300,000 blood donors) translates directly into lifesaving patient outcomes.”
Quoting Versiti Inc.’s post:
“In response to an urgent request from a major West Coast medical center, the National Blood Exchange reached out across member facilities, asking if any of them could quickly address a critical need for a patient. Versiti answered the call.
Read the full story.”
Follow the latest in Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health